Company Filing History:
Years Active: 2013
Title: Norbert Göbels: Innovator in Tumor-Specific Antibodies
Introduction
Norbert Göbels is a prominent inventor based in Düsseldorf, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of novel human tumor-specific antibodies.
Latest Patents
Norbert Göbels holds a patent for a monoclonal human tumor-specific antibody. This patent describes novel human tumor-specific antibodies, as well as fragments, derivatives, and variants that recognize the tumor-associated antigen NY-ESO-1. Additionally, the patent includes pharmaceutical compositions comprising such antibodies and mimics for the treatment of tumors.
Career Highlights
Norbert Göbels is affiliated with the University of Zurich, where he continues to advance research in the field of immunology and cancer treatment. His work has been instrumental in developing targeted therapies that can improve patient outcomes.
Collaborations
He collaborates with notable colleagues, including Christoph Esslinger and Sandra Künzle, who contribute to his research efforts and innovations in the field.
Conclusion
Norbert Göbels is a key figure in the development of tumor-specific antibodies, with a focus on innovative treatments for cancer. His contributions to biotechnology are paving the way for future advancements in cancer therapy.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.